Phase 2 trial of Oxford Covid vaccine to begin today
The observer-blind, randomised controlled study to determine the safety and immunogenicity of "Covishield" on healthy Indian adults will begin at Bharati Vidyapeeth Medical College and Hospital in Pune.
from Times of India https://ift.tt/2Qt0Zt3
from Times of India https://ift.tt/2Qt0Zt3
No comments